PALMISIS™ Product Overview
Designed for supportive nutritional care in adults, PALMISIS™ may be considered as part of a broader approach to pain-management support and ortho-neuro wellness, alongside appropriate medical guidance and healthy lifestyle measures.
The formulation brings together three ingredients with complementary nutritional and biological roles. Its suitability should be assessed according to individual needs and applicable product labelling.
Composition & Therapeutic Profile
PALMISIS™ combines three ingredients in a single nutraceutical formulation, each with a distinct nutritional or biological role.
Composition
Micronized Palmitoylethanolamide (PEA) 300 mg + L-Carnosine 200 mg + L-Arginine 50 mg
Therapeutic Class
Nutraceutical / supportive formulation
Therapeutic Focus
Supportive nutritional care in chronic pain strategies
The Science Behind PALMISIS™
Palmitoylethanolamide (PEA) is an endogenous fatty-acid amide studied for its involvement in neuroimmune signalling and inflammatory pathways.
L-Carnosine is a naturally occurring dipeptide that has been investigated for its antioxidant activity and role in cellular processes.
L-Arginine is an amino acid used by the body in several physiological processes, including nitric oxide production.
Together, these ingredients form the PALMISIS™ nutraceutical composition. Their inclusion does not, by itself, establish a clinical benefit for a particular condition. Suitability and use should be guided by the product label and advice from a qualified healthcare professional.
Clinical & Nutritional Support Areas
Complementary Support Within a Broader Care Plan
PALMISIS™ is positioned as a nutraceutical formulation for adults who may require nutritional support as part of a broader approach to pain management and ortho-neuro wellness.
Pain-Management Support
May be considered as part of a comprehensive pain-management strategy guided by a qualified healthcare professional.
Ortho-Neuro Nutritional Support
Provides a combination of PEA, L-carnosine and L-arginine for supportive nutritional care where appropriate.
Individualised Care Approach
Use should take account of individual needs, existing medical conditions, concomitant medicines and approved product labelling.
Frequently Asked Questions
PALMISIS is a nutraceutical combining micronized PEA, L-carnosine and L-arginine.
It is presented as a nutraceutical formulation; use and claims should follow applicable regulatory requirements.
No. It is intended as supportive care and should not replace clinically indicated treatment.
Discover Our Specialty Pharmaceutical Portfolio
Explore the MERGA and PRINCEPS divisions of Seginus Pharma and discover our portfolio of pharmaceutical products across key therapeutic areas.
